New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD
They\u2019re here: the 96-week data on aflibercept 8 mg (Eylea, Regeneron) in wet AMD. Jean-Francois Korobelnik, MD, PhD stops by to review the 96-week data from PULSAR. How closely did the 96-week results match those at 48 weeks? And how many patients could be extended to 16-, 20-, or even 24-week intervals?\xa0\n\xa0\nAlso, W. Lloyd Clark, MD, joins the show to discuss home-based OCT-guided management of wet AMD. How does home OCT fit into a patient\u2019s life\u2014and how might it shape the future of care? Listen here to find out.